Prior use of therapeutic anticoagulation does not protect against COVID‐19 related clinical outcomes in hospitalized patients: A propensity score‐matched cohort study

The hypercoagulable state observed in COVID‐19 could be responsible for morbidity and mortality. In this retrospective study we investigated whether therapeutic anticoagulation prior to infection has a beneficial effect in hospitalized COVID‐19 patients. This study included 1154 COVID‐19 patients ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiegelenberg, Janneke P., van Gelder, Marleen M. H. J., Maas, Martje L., Hovens, Marcel M. C., Esselink, Anne, Dofferhoff, Anton S. M., Janssen, Rob, van de Maat, Josephine, Janssen, Nico, Blaauw, Marc, Hassing, Robert‐Jan, van Apeldoorn, Marjan, Kerckhoffs, Angèle, Veerman, Karin, Hoogerwerf, Jacobien, Kramers, Cornelis, Leentjens, Jenneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250934/
https://www.ncbi.nlm.nih.gov/pubmed/33899226
http://dx.doi.org/10.1111/bcp.14877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250934/
https://www.ncbi.nlm.nih.gov/pubmed/33899226
http://dx.doi.org/10.1111/bcp.14877

Ejemplares similares